High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy
- PMID: 21640507
- DOI: 10.1016/j.ijrobp.2011.04.054
High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy
Abstract
Purpose: To investigate the pattern of lymph node spread in prostate cancer patients with a biochemical recurrence after radical prostatectomy, eligible for salvage radiotherapy; and to determine whether the clinical target volume (CTV) for elective pelvic irradiation in the primary setting can be applied in the salvage setting for patients with (a high risk of) lymph node metastases.
Methods and materials: The charts of 47 prostate cancer patients with PSA recurrence after prostatectomy who had positive lymph nodes on magnetic resonance lymphography (MRL) were reviewed. Positive lymph nodes were assigned to a lymph node region according to the guidelines of the Radiation Therapy Oncology Group (RTOG) for delineation of the CTV for pelvic irradiation (RTOG-CTV). We defined four lymph node regions for positive nodes outside this RTOG-CTV: the para-aortal, proximal common iliac, pararectal, and paravesical regions. They were referred to as aberrant lymph node regions. For each patient, clinical and pathologic features were recorded, and their association with aberrant lymph drainage was investigated. The distribution of positive lymph nodes was analyzed separately for patients with a prostate-specific antigen (PSA) <1.0 ng/mL.
Results: MRL detected positive aberrant lymph nodes in 37 patients (79%). In 20 patients (43%) a positive lymph node was found in the pararectal region. Higher PSA at the time of MRL was associated with the presence of positive lymph nodes in the para-aortic region (2.49 vs. 0.82 ng/mL; p = 0.007) and in the proximal common iliac region (1.95 vs. 0.59 ng/mL; p = 0.009). There were 18 patients with a PSA <1.0 ng/mL. Ten of these patients (61%) had at least one aberrant positive lymph node.
Conclusion: Seventy-nine percent of the PSA-recurrent patients had at least one aberrant positive lymph node. Application of the standard RTOG-CTV for pelvic irradiation in the salvage setting therefore seems to be inappropriate.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).Cancer Treat Rev. 2015 Dec;41(10):814-20. doi: 10.1016/j.ctrv.2015.10.005. Epub 2015 Oct 23. Cancer Treat Rev. 2015. PMID: 26508669 Review.
-
Early salvage radiotherapy following radical prostatectomy.Eur Urol. 2014 Jun;65(6):1034-43. doi: 10.1016/j.eururo.2013.08.013. Epub 2013 Aug 15. Eur Urol. 2014. PMID: 23972524 Review.
-
Geographical distribution of lymph node metastases on MR lymphography in prostate cancer patients.Radiother Oncol. 2013 Jan;106(1):59-63. doi: 10.1016/j.radonc.2012.10.021. Epub 2012 Nov 27. Radiother Oncol. 2013. PMID: 23199653
-
Magnetic resonance lymphography findings in patients with biochemical recurrence after prostatectomy and the relation with the Stephenson nomogram.Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1186-91. doi: 10.1016/j.ijrobp.2012.02.039. Epub 2012 Apr 18. Int J Radiat Oncol Biol Phys. 2012. PMID: 22520482
-
Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.BJU Int. 2006 Jun;97(6):1173-8. doi: 10.1111/j.1464-410X.2006.06166.x. BJU Int. 2006. PMID: 16686707
Cited by
-
Dose outside of the prostate is associated with improved outcomes for high-risk prostate cancer patients treated with brachytherapy boost.Front Oncol. 2023 Jun 15;13:1200676. doi: 10.3389/fonc.2023.1200676. eCollection 2023. Front Oncol. 2023. PMID: 37397380 Free PMC article.
-
The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer.Nat Rev Urol. 2022 Aug;19(8):475-493. doi: 10.1038/s41585-022-00618-w. Epub 2022 Jul 4. Nat Rev Urol. 2022. PMID: 35789204 Review.
-
PET/CT-Based Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy: Impact on Treatment Management and Future Directions.Front Oncol. 2021 Aug 31;11:742093. doi: 10.3389/fonc.2021.742093. eCollection 2021. Front Oncol. 2021. PMID: 34532294 Free PMC article. Review.
-
The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy.Front Oncol. 2021 Jan 8;10:590722. doi: 10.3389/fonc.2020.590722. eCollection 2020. Front Oncol. 2021. PMID: 33489887 Free PMC article.
-
Magnetic resonance imaging at ultra-high magnetic field strength: An in vivo assessment of number, size and distribution of pelvic lymph nodes.PLoS One. 2020 Jul 31;15(7):e0236884. doi: 10.1371/journal.pone.0236884. eCollection 2020. PLoS One. 2020. PMID: 32735614 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous